Community/Retail

Researchers uncover key factors influencing glucose fluctuations in type 2 diabetes, highlighting the importance of continuous glucose monitoring for effective management.

Align your financial planning with your life goals, ensuring your money serves your dreams and not the other way around.

Home monitoring enhances pediatric asthma management, boosting patient engagement and awareness while providing valuable medical feedback for better control.

Young adults with high LDL-C levels face significant gaps in statin initiation and follow-up testing, highlighting urgent needs for improved cardiovascular care.

New findings reveal lorundrostat significantly lowers blood pressure and albuminuria in chronic kidney disease patients, enhancing standard treatment efficacy.

Amir Masood, PharmD, is director of pharmacy operations at Safeway – Mid-Atlantic Division.

New research shows that an increased consumption of ultra-processed foods significantly raises prediabetes risk in young adults, highlighting urgent dietary intervention needs.

New research reveals similar severe outcomes for adults hospitalized with hMPV and RSV, emphasizing the need for awareness of both infections.

A series of predictors were associated with a higher likelihood of intensive care unit (ICU) admission and subsequently poor outcomes in patients with Streptococcus pneumoniae bacteremia.

A nasal vaccine against whooping cough shows promise in blocking infection and enhancing respiratory immunity, offering a needle-free solution.

Discover how objective activity monitoring with accelerometers transforms cardiovascular risk assessment and treatment evaluation, enhancing patient care for pharmacists.

Hypertensive disorders of pregnancy confer increased cardiovascular risk, with heightened risk corresponding to more severe hypertension.

Expert highlights the benefits of early combination therapy in hypertension management, emphasizing improved blood pressure control and reduced side effects.

Only Humans Can Ensure AI Is Ethical and Unbiased

Semaglutide shows significant weight loss and reduces obesity-related health risks, offering a promising solution for effective weight management.

Expert reveals ongoing disparities in heart valve disease care, stressing the need for improved diagnosis and treatment equity for vulnerable populations.

Boehringer Ingelheim showcases its commitment to cardio-kidney-metabolic research, highlighting innovative therapies and advancements at AHA 2025.

Discover how emerging therapies in cardio-kidney-metabolic health reshape disease management at AHA 2025, highlighting interconnected health pathways.

Metformin may hinder exercise benefits, impacting blood vessel function and insulin control, raising concerns for diabetes management during physical activity.

At 3 and 9 months, inclisiran reduced low-density lipoprotein cholesterol in patients intolerant to statins or proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors at rates comparable to those in placebo-controlled trials.

The Latest Kaiser Family Foundation Employer Health Benefits Survey Has Unsurprising but Consequential Findings

Integrating a pharmacist into multidisciplinary settings allowed for more thorough LDL-C lowering in unique settings.

Researchers unveil a pharmacist-led intervention to enhance hypoglycemia management in older adults with type 2 diabetes, improving patient outcomes.

A new wrist-worn accelerometer device effectively monitors activity levels in heart failure patients, revealing critical insights into cardiovascular health.

The FDA lifts the black box warning on hormone replacement therapy, empowering women with new options for managing menopause symptoms.

Recent analysis reveals no significant link between maternal acetaminophen use and increased autism or ADHD risk, challenging previous health claims.

Inclisiran significantly enhances LDL-C goal attainment in post-acute coronary syndrome patients, improving lipid management outcomes.